ARID1A gene mutation in ovarian and endometrial cancers (Review)

By Takeda Takashi   Banno Kouji   Okawa Ryuichiro   Yanokura Megumi   Iijima Moito   IrieKunitomi Haruko   Nakamura Kanako   Iida Miho   Adachi Masataka   Umene Kiyoko   Nogami Yuya   Masuda Kenta   Kobayashi Yusuke   Tominaga Eiichiro   Aoki Daisuke  

Oncology Reports, Vol. 35, Iss. 2, 2016-02 ,pp. : 607-613

Spandidos Publications

Access to resources Recommend Favorite

Somatic Mutation of PARK2 Tumor Suppressor Gene is not Common in Common Solid Cancers

By Je Eun  

Pathology & Oncology Research, Vol. 19, Iss. 3, 2013-07 ,pp. : 393-395

Springer Publishing Company

Access to resources Recommend Favorite

Loss of Expression of the p16 Tumor Suppressor Gene Is More Frequent in Advanced Ovarian Cancers Lacking p53 Mutations

By Havrilesky L.J.   Alvarez A.A.   Whitaker R.S.   Marks J.R.   Berchuck A.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 491-500

Elsevier

Access to resources Recommend Favorite

Frequent Down-Regulation and Lack of Mutation of the KAI1 Metastasis Suppressor Gene in Epithelial Ovarian Carcinoma

By Liu F.-S.   Dong J.-T.   Chen J.-T.   Hsieh Y.-T.   Shih-Chu Ho E.   Hung M.-J.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 10-15

Elsevier

Access to resources Recommend Favorite

Dominant-Negative Mutation of p53 Tumor Suppressor Gene in Endometrial Carcinoma

By Sakuragi N.   Hirai A.   Tada M.   Yamada H.   Yamamoto R.   Fujimoto S.   Moriuchi T.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 485-490

Elsevier

Access to resources Recommend Favorite